The purpose of the trial is to assess outcomes for different treatment modalities for PCa. Any man diagnosed with prostate cancer will be given three questionnaires every three months to assess quality of life directly related to their prostate cancer and selected treatment. Chart review is also performed to record cancer characteristics (genomics, tumor markers, MRI, pathology studies, etc.), treatments/interventions, PSA, and follow up. Patients don’t have to have a specific treatment selection, we are following surveillance, Cryo, CK/Radiation, surgery, hormones and metastatic patients. A very large substudy under the prostate cancer database is our MRI database looking at serial MRIs in prostate cancer patients on surveillance.